Stanford University
Showing 2,921-2,930 of 4,349 Results
-
Vedant Pargaonkar
Basic Life Science Research Associate, Medicine - Med/Cardiovascular Medicine
BioMy long-term research interests involve development of algorithms using computational methods for early detection of coronary pathophysiology including, endothelial dysfunction and microvascular dysfunction (MVD) and/or a myocardial bridge (MB) in patients with angina and no obstructive coronary artery disease (NOCAD) and the identification of novel target therapies for primary prevention and improved prognosis in these patients. Under the mentorship of Dr. Jennifer Tremmel in Cardiovascular medicine at Stanford, I have been systematically studying to better understand the underlying pathophysiology of these patients, as well as the optimal use of diagnostic testing and treatment using the angina and no-obstructive CAD Registry at Stanford. In collaboration with other investigators in this field, we have published multiple scientific articles highlighting the limitations of current testing in this population and identification of novel diagnostic tools for early diagnosis and management of patients with angina and no obstructive CAD. My research also focuses on myocardial infarction (MI) in women, particularly spontaneous coronary artery dissection (SCAD). I have been involved in the design and execution of the first international collaborative study in SCAD, investigating peripartum vs. non-peripartum SCAD. This is analyzing the largest cohort of patients recruited from multiple US and non-US sites to understand the pathophysiological differences in these patient cohorts.
-
Mitchel Pariani
Clinical Assistant Professor (Affiliated), Pediatrics - Genetics
BioMitchel earned his Master’s degree in genetic counseling from California State University, Northridge in 2007. At Cedars-Sinai Medical Center Mitchel served as genetic counselor and coordinator for David Rimoin, MD, PhD’s connective tissue disorders clinic and later established the cardiovascular genetics program at CSMC. At CSMC he also created the CSMC Summer Genetic Counseling Rotation Program that hosted students from genetic counseling programs around the United States. In 2014 he joined the new Stanford Center for Inherited Cardiovascular Disease to start a familial hypercholesterolemia clinic and provide genetic counseling for patients with cardiomyopathies. As the center expanded, Mitchel joined the Stanford Marfan Center as a genetic counselor and serves as program coordinator. He is the primary instructor for Stanford’s Cardiovascular Genetics course and serves as a clinical supervisor and mentor for students and volunteers.
-
Jun Hyung Park
Research and Development Science and Engineer 1, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordI joined in Stanford Cyclotron and Radiochemistry Facility in 2014. I focus on routine radiopharmaceutical production, development, optimization for clinical use and supporting various of pre-clinical studies.
18F tracers; 18F-Flumazenil, 18F-FTC-146, 18F-FLT, 18F MISO, 18F AraG, 18F-FSPG etc.
11C tracers; 11C UCB-J, 11C-raclopride, 11C-PIB, 11C-methionine, 11C DPA-713, 11C MGX10, 11, 11C-CN radiochemistry platform development
15O tracers; 15O-H2O, 15O gas Inhalation study
68Ga tracers; 68Ga-DOTATATE, 68Ga-PSMA
Quality Controls; HPLC, GC, TCD GC etc. -
KT Park MD MS
Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology
BioPrior to joining Genentech in 2018, Dr. Park was Associate Professor at Stanford University School of Medicine, Co-Director of the IBD Center at Stanford Children’s Health, and an expert in Crohn’s disease and ulcerative colitis. Currently, he is the Global Head of Gastroenterology, Hepatology & Metabolism in Product Development at Genentech and Roche. Trained as a health economist, during his tenure in academia, Dr Park held research grants and funding support focused on the cost-effectiveness of biologic treatment strategies and novel non-invasive biomarkers for children and adults with IBD. He led national research registries at the Crohn’s & Colitis Foundation and scientific/clinical committees in numerous GI societies and physicians’ organizations. He received his BA in chemistry/biochemistry at Duke University, MD at University of Tennessee, and MSc in Health Economics/Policy at Stanford where he completed his clinical and postdoctoral trainings. He is Adjunct Professor of Medicine in the Division of Gastroenterology & Hepatology at Stanford University. At Genentech Roche, Dr. Park directs a team of clinical scientists and medical directors overseeing clinical phase drug development in gastroenterology, hepatology, and metabolism.
